A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma
NCT00944567 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125
Last updated 2017-08-15
Summary
A non-profit study designed with the aim of analysing the phenotype and molecular characteristics (central review) and evaluating prospectively the role of PET-scans in the management of primary mediastinal lymphoma treated with conventional approaches.
Conditions
- Primary Mediastinal B-Cell Lymphoma
Sponsors & Collaborators
-
International Extranodal Lymphoma Study Group (IELSG)
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2011-05-31
- Completion
- 2017-02-27
Countries
- Italy
- Spain
- Switzerland
- United Kingdom
Study Locations
More Related Trials
-
Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma
NCT01599559 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-A33/KEYNOTE-A33)
NCT04317066 ·Status: COMPLETED ·Phase: PHASE1
-
Refractory Diffuse Large B-cell Lymphoma
NCT03664336 ·Status: COMPLETED
-
Relmacabtagene Autoleucel in Patients With LBCL
NCT06142175 ·Status: RECRUITING
-
Mediastinal Grey Zone Lymphoma From the LYSA
NCT03037177 ·Status: COMPLETED
-
Study of LP002 for the Treatment of Patients With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma
NCT04600947 ·Status: UNKNOWN ·Phase: PHASE2
-
Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With DLBCL: a Phase II Multicenter Study of the FIL
NCT01990144 ·Status: UNKNOWN ·Phase: PHASE2
-
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma
NCT01369784 ·Status: COMPLETED
-
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
NCT06806488 ·Status: RECRUITING
-
Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)
NCT02412267 ·Status: COMPLETED ·Phase: PHASE2
-
Mediastinal Recurrence of Lympho-proliferative Disorders: a Biopsy is Needed
NCT06714045 ·Status: COMPLETED
-
A Phase I/II Study of Diffuse Large B-cell Lymphoma
NCT04856137 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region
NCT07065344 ·Status: NOT_YET_RECRUITING
-
An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma
NCT01340443 ·Status: COMPLETED
-
A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
NCT05444322 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study on Plasmablastic Lymphoma Patients
NCT06781359 ·Status: RECRUITING
-
Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma
NCT06744075 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma
NCT05459571 ·Status: COMPLETED ·Phase: PHASE2
-
Primary Cardiac Lymphoma: Italian Multicenter Experience
NCT05819528 ·Status: RECRUITING
-
Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma
NCT05590221 ·Status: RECRUITING ·Phase: PHASE2
-
Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma
NCT05422521 ·Status: RECRUITING ·Phase: NA
-
Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)
NCT05253118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Low Dose Radiotherapy in Primary Indolent Cutaneous B-cell Lymphoma
NCT07310745 ·Status: ACTIVE_NOT_RECRUITING
-
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
NCT05700149 ·Status: RECRUITING
-
Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma
NCT00645359 ·Status: TERMINATED